0001209191-21-017475.txt : 20210303 0001209191-21-017475.hdr.sgml : 20210303 20210303201621 ACCESSION NUMBER: 0001209191-21-017475 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210301 FILED AS OF DATE: 20210303 DATE AS OF CHANGE: 20210303 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: FEES JESSICA CENTRAL INDEX KEY: 0001760391 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38459 FILM NUMBER: 21711929 MAIL ADDRESS: STREET 1: C/O SURFACE ONCOLOGY, ICN. STREET 2: 50 HAMPSHIRE STREET 8TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Surface Oncology, Inc. CENTRAL INDEX KEY: 0001718108 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 50 HAMPSHIRE STREET, 8TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-714-4096 MAIL ADDRESS: STREET 1: 50 HAMPSHIRE STREET, 8TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-03-01 0 0001718108 Surface Oncology, Inc. SURF 0001760391 FEES JESSICA C/O SURFACE ONCOLOGY, INC. 50 HAMPSHIRE STREET, 8TH FLOOR CAMBRIDGE MA 02139 0 1 0 0 See Remarks Stock Option (Right to Buy) 9.02 2021-03-01 4 A 0 68000 0.00 A 2031-03-01 Common Stock 68000 68000 D This option shall become exercisable in equal monthly installments over four years following February 9, 2021, so long as the reporting person remains an employee or other service provider of the Company on such dates. Title: Principal Accounting Officer, Principal Financial Officer /s/ Jessica Fees 2021-03-03